By Natasha Roberts
Date: Friday 26 Oct 2012
A round-up of the biggest director deals today so far.
| Monday broker round-up - UPDATE | 22-Oct-2012 | ShareCast |
| Small caps round-up: Angel Biotech, Alliance Pha... | 19-Oct-2012 | ShareCast |
| Friday broker round-up - UPDATE | 19-Oct-2012 | ShareCast |
| Alliance Pharma sales fall 10 per cent | 12-Sep-2012 | ShareCast |
| Small caps round-up: Gresham Computing, Alliance... | 10-Jul-2012 | ShareCast |
| AGM Statement | 22-May-2013 | 07:00 | RNS |
| CULS Conversion and Additional Listing | 13-May-2013 | 13:22 | RNS |
| CULS Conversion and Additional Listing | 23-Apr-2013 | 14:36 | RNS |
| CULS Conversion and Additional Listing | 15-Apr-2013 | 12:13 | RNS |
| Annual Report and Accounts | 11-Apr-2013 | 15:37 | RNS |
| Drug sales lead the way for Boots as revenues ri... | 31-Oct-2008 | The Scotsman |
| Look ahead | 13-Sep-2006 | Times |
| Look ahead | 12-May-2006 | Times |
| Peerless to widen its search | 24-May-2003 | Telegraph |
| Investment Column : Alliance Pharma | 09-Sep-2010 | The Independent |
| Investment Column:Alliance Pharma | 19-Mar-2009 | The Independent |
| Market report: Thursday latest | 13-Sep-2007 | Daily Mail |
| Gloomy summer casts shadow over Next | 10-Sep-2007 | The Independent |
| Exchange on high after stock upgrade | 11-Nov-2004 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 36.38p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 38.50p |
| 52 Week Low | 23.00p |
| Volume | 29,967 |
| Shares Issued | 248.57m |
| Market Cap | £90.42m |
| Beta | 0.06 |
| RiskGrade | 80 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 12-Jun-13 | 05-Dec-12 |
| Paid | 11-Jul-13 | 15-Jan-13 |
| Amount | 0.55p | 0.28p |
| Time | Volume / Share Price |
| 15:04 | 8,193 @ 36.61p |
| 12:47 | 12,150 @ 36.71p |
| 10:51 | 6,000 @ 36.19p |
| 09:41 | 3,624 @ 36.20p |
| CEO | John Dawson |
| Finance Director | Richard Wright |
You are here: research